摘要:
Compounds having Formula (I) are useful for treating inflammation. Also disclosed are pharmaceutical compositions comprising compouns of Formula (I), and methods of inhibiting/treating inflammatory diseases in a mammal.
摘要:
A compound of formula (I) or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要:
A compound of formula (I) or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要:
L'invention concerne un composé d'inhibition de la rénine ayant la formule (I), dans laquelle A est un substituant; R1 représente hydrogène, alkyl inférieur, alkyl inférieur substitué ou alkényl inférieur; X représente CH2, CHOH, C(O), O, S, S(O), SO2, NH, N(O) ou -P(O)O-; R3 représente un alkyl inférieur, un alkényl inférieur ou un alkyl inférieur substitué; et T est une mimique du site de clivage Leu-Val de l'angiotensinogène; ou un sel, un ester ou un promédicament pharmaceutiquement acceptable de celui-ci.
摘要:
A compound of formula (I) or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要:
The present invention relates to cinnamide compounds of formula (I), in which at least one of R1 to R5 is a "cis-cinnamide" (a) or a "trans-cinnamide" (b) and the other variables are as defined in the claims, that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions containing these compounds and to methods of inhibiting inflammation or suppressing immune response in a mammal.
摘要:
A compound of formula (I), or a pharmaceutically acceptable salt thereof, is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要:
Composé inhibant la rénine, de la formule (I), dans laquelle X représente O, NH ou S et G représentent un mime du site de clivage Leu-Val d'angiotensinogène; ou un sel un ester ou un promédicament pharmaceutiquement acceptable dudit composé; à condition que le composé ne soit pas N-(3-(4-morpholino)propyl)-5(S)-(2(S)-(1(S)-(4-méthoxyméthoxy)pipéridine-1-yl)carbonyl-2-phényl)éthoxyhéxanamido)-6-cyclohéxyl-4(S)-hydroxy-2(S)-isopropylhéxanamide.
摘要:
L'invention concerne un composé inhibiteur de protéase rétrovirale de la formule (I), ou un sel, un promédicament ou un ester pharmaceutiquement acceptable de celui-ci.
摘要:
A compound of formula (I), or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.